Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis

Importance/Background: The coronavirus disease (COVID-19) pandemic is a critical public health issue. Evidence has shown that metformin favorably influences COVID-19 outcomes. This study aimed to assess the benefits and risks of metformin in COVID-19 patients. Methods: We searched the PubMed, Embase...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yin, Yang, Xue, Yan, Peijing, Sun, Tong, Zeng, Zhi, Li, Sheyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416892/
https://www.ncbi.nlm.nih.gov/pubmed/34490296
http://dx.doi.org/10.3389/fmed.2021.704666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416892/
https://www.ncbi.nlm.nih.gov/pubmed/34490296
http://dx.doi.org/10.3389/fmed.2021.704666

Ejemplares similares